Neuroimmunology
Time for What Matters: Ocrevus SC
In conversation with
Dr Barry A. Singer
The MS Center for Innovations in Care
Missouri Baptist Medical Center
St. Louis, Missouri, USA
Wednesday, October 21
Industry Theatre
10:50 - 11:10 AM
For a decade, Ocrevus has defined high-efficacy care in Multiple Sclerosis. Now, Ocrevus SC is redefining the patient experience. By merging the best MS treatment power of B-cell depletion with a twice-yearly 10-minute subcutaneous delivery, we are giving patients back their most valuable resource: time.
MS, Multiple Sclerosis; SC, Subcutaneous
These Roche-sponsored events are intended for HCPs and members of the scientific community and are not intended for physicians practising in the United States of America (USA). The data and presentations are based on European Medicines Agency (EMA) regulations and labels. Content presented herein may discuss formulations, indications, or data that are not approved or aligned with the labelling in other jurisdictions. Local prescribing information should always be consulted. Subcutaneous Ocrevus is not authorized for sale in Canada.
Roche proactively tries to ensure medical education is as widely accessible as possible for HCPs all over the world. These events are organised and funded by Roche.
The content of these events is owned by: F. Hoffmann-La Roche Ltd, 4070 Basel, Switzerland.
© 2026 F. Hoffmann-La Roche Ltd. All trademarks mentioned herein are protected by law. www.roche.com.